New study maps the journey of rare disease MLIV
NCT ID NCT05782387
First seen May 01, 2026 · Last updated May 25, 2026 · Updated 3 times
Summary
This study looks back at medical records of 50 people with mucolipidosis type IV (MLIV) to understand how the disease progresses. Researchers will track when children reach or lose developmental milestones, how movement and vision change, and what brain scans show. No new treatment is given; the goal is to learn more about MLIV to help plan future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCOLIPIDOSIS TYPE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02144, United States
Conditions
Explore the condition pages connected to this study.